ZAK gRNA (BRDN0001146540) Citations (1)

Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal

---

Articles Citing ZAK gRNA (BRDN0001146540)

Articles
Viperin triggers ribosome collision-dependent translation inhibition to restrict viral replication. Hsu JC, Laurent-Rolle M, Pawlak JB, Xia H, Kunte A, Hee JS, Lim J, Harris LD, Wood JM, Evans GB, Shi PY, Grove TL, Almo SC, Cresswell P. Mol Cell. 2022 May 5;82(9):1631-1642.e6. doi: 10.1016/j.molcel.2022.02.031. Epub 2022 Mar 21. PubMed

If you have published an article using this material, please email us at to have your article added to this page.